Aflac
AFL NYSE Life & Health Insurance Financials FY2016βFY2025
Aflac's revenue fell 9.3% to $17.2 billion in fiscal 2025. Its net margin was 21.2%, down from 28.8% a year earlier. It paid out $4.7 billion in dividends and buybacks. The diluted share count fell 5.3%.
About these figures. Debt is Aflac's notes payable, the balance sheet's debt line without its lease obligations. Aflac's cash flow statement doesn't show its spending on property and equipment as a line of its own, so capital spending and free cash flow are left blank.
What Aflac does
No business description yet.
- Legal name
- Aflac Incorporated
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-011402
0000004977
Revenue and margins
Aflac had $17.2B of revenue in fiscal 2025, down 9.3% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 8.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Aflac returned $4.7B to shareholders in fiscal 2025. The diluted share count fell 5.3%.
Value Aflac yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$2.1B and divides by 534.9M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 13.0x Β· peers 12.9x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Aflac can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $5.1B | $3.9B | $4.3B | $6.2B | $6.2B |
| Debt incl. finance leases | $7.9B | $7.3B | $7.2B | $7.4B | $8.3B |
| Net debt / EBITDA | 0.6x | 0.8x | 0.5x | 0.2x | 0.4x |
| Debt / equity | 0.5x | 0.4x | 0.3x | 0.3x | 0.3x |
| Interest coverage | 20.7x | 18.4x | 28.0x | 34.1x | 21.9x |
| Total assets | $157.5B | $131.7B | $126.7B | $117.6B | $116.5B |
| Total liabilities | $124.3B | $111.6B | $104.7B | $91.5B | $87.0B |
| Shareholders' equity | $17.0B | $20.1B | $22.0B | $26.1B | $29.5B |
| Net debt (β = net cash) | $2.8B | $3.4B | $2.9B | $1.2B | $2.1B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$37.6M
1 insider
Of sales under plans
100%
$37.6M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Japan Post Holdings Co. Ltd.10% owner | Sold plan | 113,611 | $118.53 | $13.5M | Form 4 |
| Oct 14, 2026 | Japan Post Holdings Co. Ltd.10% owner | Sold plan | 55,000 | $117.79 | $6.5M | Form 4 |
| Oct 13, 2026 | Japan Post Holdings Co. Ltd.10% owner | Sold plan | 42,000 | $116.38 | $4.9M | Form 4 |
| Oct 12, 2026 | Japan Post Holdings Co. Ltd.10% owner | Sold plan | 12,200 | $115.85 | $1.4M | Form 4 |
| Oct 9, 2026 | Japan Post Holdings Co. Ltd.10% owner | Sold plan | 12,000 | $114.72 | $1.4M | Form 4 |
| Oct 8, 2026 | Japan Post Holdings Co. Ltd.10% owner | Sold plan | 13,000 | $114.45 | $1.5M | Form 4 |
| Oct 7, 2026 | Japan Post Holdings Co. Ltd.10% owner | Sold plan | 12,000 | $112.80 | $1.4M | Form 4 |
| Oct 6, 2026 | Japan Post Holdings Co. Ltd.10% owner | Sold plan | 13,050 | $113.49 | $1.5M | Form 4 |
| Oct 5, 2026 | Japan Post Holdings Co. Ltd.10% owner | Sold plan | 13,000 | $112.25 | $1.5M | Form 4 |
| Oct 2, 2026 | Japan Post Holdings Co. Ltd.10% owner | Sold plan | 13,200 | $111.30 | $1.5M | Form 4 |
| Oct 1, 2026 | Japan Post Holdings Co. Ltd.10% owner | Sold plan | 11,900 | $111.18 | $1.3M | Form 4 |
| Sep 29, 2026 | Japan Post Holdings Co. Ltd.10% owner | Sold plan | 12,100 | $113.36 | $1.4M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | 1.1% | 2.2% | 0.9% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Aflac AFL | $60.9B | β9.3% | β | β | 13.0% | 13.0x | β | |
| Principal Financial Group PFG | $23.9B | β3.1% | β | β | β | 15.6x | β | Compare β |
| Unum UNM | $14.4B | 1.5% | β | 4.3% | 7.6% | 21.0x | β | Compare β |
| Brighthouse Financial BHF | $2.6B | 43.2% | β | β | β | 3.6x | β | Compare β |
| Globe Life GL | $12.2B | 3.7% | β | 20.9% | 16.0% | 10.3x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $22.6B | $21.7B | $21.8B | $22.3B | $22.1B | $21.6B | $19.1B | $18.7B | $18.9B | $17.2B |
| Operating income | $4.1B | $4.1B | $4.4B | $4.5B | $4.4B | $4.9B | $4.2B | β | β | β |
| Interest expense | $268M | $240M | $222M | $228M | $242M | $238M | $226M | $195M | $194M | $217M |
| Pretax income | $4.1B | $4.0B | $4.0B | $4.4B | $4.2B | $5.2B | $4.9B | $5.3B | $6.4B | $4.5B |
| Income tax | $1.4B | β$586M | $1.1B | $1.1B | β$619M | $977M | $451M | $603M | $974M | $887M |
| Net income | $2.7B | $4.6B | $2.9B | $3.3B | $4.8B | $4.2B | $4.4B | $4.7B | $5.4B | $3.6B |
| Diluted EPS | $3.21 | $5.77 | $3.77 | $4.43 | $6.67 | $6.25 | $6.93 | $7.78 | $9.63 | $6.82 |
| Diluted shares | 0.83B | 0.80B | 0.77B | 0.75B | 0.72B | 0.68B | 0.64B | 0.60B | 0.57B | 0.53B |
| Cash flow | ||||||||||
| Cash from operations | $6.0B | $6.1B | $6.0B | $5.5B | $6.0B | $5.1B | $3.9B | $3.2B | $2.7B | $2.6B |
| Depreciation and amortization | $54.0M | $53.0M | $49.0M | $41.0M | $41.0M | $45.0M | $45.0M | $39.0M | $40.0M | $36.0M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $1.4B | $1.4B | $1.3B | $1.6B | $1.5B | $2.3B | $2.4B | $2.8B | $2.8B | $3.5B |
| Dividends paid | $658M | $661M | $793M | $771M | $769M | $855M | $979M | $966M | $1.1B | $1.2B |
| Dividends and buybacks | $2.1B | $2.0B | $2.1B | $2.4B | $2.3B | $3.2B | $3.4B | $3.8B | $3.9B | $4.7B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $4.9B | $3.5B | $4.3B | $4.9B | $5.1B | $5.1B | $3.9B | $4.3B | $6.2B | $6.2B |
| Total debt | $5.3B | $5.3B | $5.8B | $6.4B | $7.7B | $7.8B | $7.3B | $7.2B | $7.4B | $8.3B |
| Finance lease liabilities | $0.0M | $0.0M | $13.0M | $12.0M | $11.0M | $12.0M | $8.0M | $6.0M | $5.0M | $6.0M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $433M | $434M | $443M | $581M | $601M | $538M | $530M | $445M | $387M | $351M |
| Total assets | $129.8B | $137.2B | $140.4B | $152.8B | $165.1B | $157.5B | $131.7B | $126.7B | $117.6B | $116.5B |
| Total liabilities | $109.3B | $112.6B | $116.9B | $123.8B | $131.5B | $124.3B | $111.6B | $104.7B | $91.5B | $87.0B |
| Shareholders' equity | $20.5B | $24.6B | $23.5B | $29.0B | $33.6B | $17.0B | $20.1B | $22.0B | $26.1B | $29.5B |
| Margins | ||||||||||
| Operating margin | 18.3% | 18.9% | 20.0% | 20.0% | 19.9% | 22.9% | 21.7% | β | β | β |
| EBITDA margin | 18.5% | 19.1% | 20.2% | 20.2% | 20.1% | 23.1% | 22.0% | 29.4% | 35.1% | 27.9% |
| Net margin | 11.8% | 21.3% | 13.4% | 14.8% | 21.6% | 19.6% | 23.1% | 24.9% | 28.8% | 21.2% |
| Returns | ||||||||||
| Return on capital | 13.7% | 17.3% | 12.5% | 12.0% | 13.3% | 14.3% | 17.4% | 20.0% | 21.5% | 13.0% |
| Return on equity | 13.9% | 20.4% | 12.2% | 12.6% | 15.3% | 16.7% | 23.8% | 22.1% | 22.6% | 13.1% |
| Return on assets | 2.1% | 3.5% | 2.1% | 2.3% | 3.0% | 2.6% | 3.1% | 3.6% | 4.5% | 3.1% |
| Growth | ||||||||||
| Revenue growth | 8.1% | β4.0% | 0.4% | 2.5% | β0.7% | β2.7% | β11.2% | β2.3% | 1.2% | β9.3% |
| Net income growth | 5.0% | 73.2% | β36.6% | 13.2% | 44.6% | β11.5% | 4.4% | 5.5% | 16.8% | β33.0% |
| EPS growth | 9.7% | 79.8% | β34.7% | 17.5% | 50.6% | β6.3% | 10.9% | 12.3% | 23.8% | β29.2% |
| Share count change | β4.4% | β3.6% | β2.9% | β3.6% | β4.1% | β5.5% | β5.8% | β6.1% | β5.6% | β5.3% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.1x | 0.4x | 0.3x | 0.3x | 0.6x | 0.6x | 0.8x | 0.5x | 0.2x | 0.4x |
| Debt / equity | 0.3x | 0.2x | 0.3x | 0.2x | 0.2x | 0.5x | 0.4x | 0.3x | 0.3x | 0.3x |
| Interest coverage | 15.4x | 17.0x | 19.6x | 19.6x | 18.3x | 20.7x | 18.4x | 28.0x | 34.1x | 21.9x |
| Quality scores | ||||||||||
| Accruals ratio | β2.7% | β1.1% | β2.2% | β1.5% | β0.7% | β0.5% | 0.4% | 1.1% | 2.2% | 0.9% |
Source: SEC EDGAR XBRL filings (CIK 0000004977). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.